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ABSTRACT
The Gene Ontology (GO) (http://www.geneontology
.org) is a community bioinformatics resource that
represents gene product function through the use
of structured, controlled vocabularies. The number
of GO annotations of gene products has increased
due to curation efforts among GO Consortium (GOC)
groups, including focused literature-based annota-
tion and ortholog-based functional inference. The
GO ontologies continue to expand and improve as
a result of targeted ontology development, including
the introduction of computable logical definitions
and development of new tools for the streamlined
addition of terms to the ontology. The GOC con-
tinues to support its user community through the
use of e-mail lists, social media and web-based
resources.
INTRODUCTION
The Gene Ontology (GO; http://www.geneontology.org)
project is a bioinformatics resource that provides the sci-
entific community with information about gene-product
function (1) through the use of domain specific ontologies.
The project consists of a collaborative effort to ‘annotate’
gene products (e.g. proteins) with terms that describe their
functions and cellular location of action. A ‘GO annota-
tion’ is an association, supported by evidence, between a
gene product and a term from one of the structured,
controlled vocabularies that describe how and where
gene products act. Founded in 1998, the GO has grown
to become an integrated resource containing functional in-
formation for over 11 million gene products from over
350 000 species (including strains) covering plants,
animals and the microbial world. The GOC makes all an-
notations, vocabularies and tools freely available. Recent
improvements to the GO resource include: expansion and
refinement of the gene annotation set, further develop-
ment of the ontology into key areas of biology,
improved formalization of ontology structure and en-
hancements for biological investigation by researchers
using the GO.
EXPANDED AND REFINED GENE-PRODUCT
ANNOTATIONS
Increased annotation breadth and depth
Table 1 shows a summary of annotations available from
the GO resource.
A major collaborative effort within the GOC has
focused on providing a set of comprehensive experimental
GO annotations for all gene products for human and 11
reference genomes of major model organisms, as well as
tools for using these annotations to infer GO annotations
for all fully sequenced genomes (Table 2). Through this
project, GOC member databases have continued their
efforts to provide a better annotation resource (2).
Coordination through the reference genome project
allows annotator interaction that ensures consistent anno-
tation practice and allows for simultaneous development
of the ontology as annotation progresses. The reference
genome annotation project has been greatly enhanced
by the use of the PAINT tool to infer functional informa-
tion across closely related genes in a wide variety of
organisms (3).
Introduction of GAF2.0
GO annotations are used both internally for
GOC-developed tools and are provided to external devel-
opers for use in independently developed data analysis
software. The GOC uses and provides annotation data
in a standardized, tab-delimited format called a gene as-
sociation file or GAF. Each line in the GAF includes in-
formation about the gene product being annotated,
evidence supporting the annotation, the group making
the annotation and the GO term associated with the an-
notation. One line represents one assertion about a gene
product and includes information about the original ref-
erence on which the assumption is based as well as the
evidence supporting that assumption. Since gene
products can be involved in more than one process,
carry out more than one function or be located in more
than one cellular component, there may be many annota-
tion lines in a GAF for a single gene product. In March
2010, the GOC began officially using an enhanced file
format: GAF2.0 (http://www.geneontology.org/GO
.format.gaf-2_0.shtml). In the GAF 2.0 format, there are
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17 tab-delimited columns. GAF 2.0 improves and expands
upon the GAF1.0 format by better capturing information
about the identity of the specific gene products being
annotated and by allowing annotations to contain con-
textual data thus enhancing the annotation specificity.
Contextual data are captured using other biomedical
ontology terms to narrow the meaning of an annotation.
For example, the use of a Cell Type (4) ontology term as
contextual data can be used to represent a process in a
specific cell type if the base annotation represents a generic
cellular process.
Improved annotation quality control
As part of the GOC’s ongoing effort to standardize and
improve annotation quality, we have also introduced a set
of ‘hard’ and ‘soft’ quality control checks on annotations
submitted by the participating groups. ‘Hard’ quality
control checks identify incorrect annotations that will
not be loaded into the GO database, but rather returned
to the contributing resource for revision. These represent
errors in annotation procedure such as annotating using
an obsolete GO term/ID or annotating to the term
’protein binding’ (GO:0005515) with an evidence code
other than ‘inferred by physical interaction’.
Soft quality control checks identify annotations that are
not necessarily incorrect, but that might be expected to
have additional supporting evidence information and
therefore should be subject to review. For example, anno-
tation to the term ‘response to stress’ could likely be
improved by specifying the type of stress. Another
example of a soft check is the taxon constraint where a
given annotation would be expected to be valid within
certain taxonomic groups. We have continued to use
and expand taxon restraints as a guide for identifying an-
notation errors (5). For example an annotation to
‘chloroplast’ should never be made for a mouse gene
product. These taxon checks are considered as soft checks.
Summary of these and other error checking rules are
available: http://www.geneontology.org/GO.annotation_
qc.shtml.
The hard checks are implemented via a filtering script
which removes offending annotations from the
gene-association files (GAF) and the cleaned up GAF
files are made available to users, loaded into the GO
database and AmiGO. For the soft checks, a rule engine
(GAF validator) allows curators to identify annotations
that need to be reviewed.
NEW FEATURES OF THE ONTOLOGIES
We have continued to improve the ontologies
themselves. A full list of projects to enhance the
ontology is available at: http://wiki.geneontology.org/
index.php/Ontology_Development
Our improvements have focused on three critical areas:
making the ontology more useful for data aggregation,
increasing biological content and improving the structure
of the ontology to better reflect our current best under-
standing of biology.
New generic GO slim
GO Slims are predetermined sets of GO terms that are
used to aggregate gene product information (http://www
.geneontology.org/GO.slims.shtml). Since the terms in a
given GO slim are manually chosen, they can be engin-
eered to have a broad coverage of biology, or specific
coverage of a limited subject area or a distribution of
coverage based on experimental parameters such as
stage of development. We have recently redesigned the
generic GO Slim. The generic GO Slim is used for a
broad categorization of the biological processes in which
a set of gene products is involved. This GO Slim consists
of 104 terms from the biological process portion of GO.
The new generic GO Slim does not contain molecular
function terms since these terms are necessarily very
specific and only represent the action of individual gene
products within a given biological process; however, we
are currently working on a separate generic GO slim for
molecular function grouping. Users can create custom GO
slims with the OBO-Edit tool. Instructions can be found in
the OBO-Edit help documentation.
Table 2. Twelve model organisms selected for targeted curation and their respective databases
Arabidopsis thaliana The Arabidopsis Information Resource (TAIR)
Caenorhabditis elegans WormBase
Danio rerio Zebrafish Information Network (Zfin)
Dictyostelium discoideum Dictybase
Drosophila melanogaster FlyBase
Escherichia coli EcoliHub
Gallus gallus AgBase
Homo sapiens Human UniProtKB-Gene Ontology Annotation [UniProtKB-GOA] @ EBI
Mus musculus Mouse Genome Informatics (MGI)
Rattus norvegicus Rat Genome Database (RGD)
Saccharomyces cerevisiae Saccharomyces Genome Database (SGD)
Schizosaccharomyces pombe GeneDB S. pombe
Table 1. Status of the Gene Ontology as of 7 September 2011
Biological process terms 21 394
Molecular function terms 9062
Cellular component terms 2896
Species with annotation (includes strains) 367 887
Total annotated gene products 11 855 555
Manually annotated gene products 437 164
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Expanded biological content
The GOC has continued to work with community experts
to expand and refine certain areas of the ontology. This
work usually includes a face-to-face meeting between com-
munity experts and ontology developers where the struc-
ture and content of the ontology is discussed. After the
meeting, ontology developers rearrange the ontology and
add new terms to the ontology with review so that it
reflects the most up to date views of the research
community.
One area of intense focus over the last year has been the
representation of transcription in GO (http://wiki
.geneontology.org/index.php/Transcription). This work
focused mainly on problematic terms in the molecular
function ontology, particularly in the area of transcription
factor function. The portion of the ontology describing
transcription factors has been split into those transcription
factors that act primarily as protein binding agents and
those that act as DNA binding agents. We took advantage
of the new has_part relationships in the ontology as well as
the recent introduction of part_of relationships between
molecular functions and biological processes so that the
new structure reflects the complex nature of the activity
of these molecules (6). For example, the molecular
function ‘sequence-specific DNA binding transcription
factor activity’ (GO:0003700) has as part of its activity
‘transcription regulatory region sequence-specific DNA
binding’ (GO:0000976), indicating that binding to the
regulatory region is necessary for the action of the gene
product. GO:0003700 is part_of ‘regulation of transcrip-
tion, DNA dependent’ (GO:0006355) (Figure 1). These
relationships show that the action of a gene product
annotated to this term controls whether or not transcrip-
tion will take place.
We have also begun to standardize the representation of
signaling in the ontology (http://wiki.geneontology.org/
index.php/Signaling). In particular, we have begun to
define the starting points and stopping points of signaling
processes. Clarifying the definitions is a great aid for both
annotators who are looking for the right term to use, as
well as for researchers looking at gene products associated
with specific points in a signaling process. The functions of
signaling ligands are represented as integral parts of the
signal transduction process. The consequence of signaling
is represented as a regulation of a cellular process. We
have disentangled the processes that represent the
complexities of ligand–receptor interactions where a
single ligand can activate multiple transduction
pathways and multiple ligands can activate the same
pathway.
Kidney development is an area of biology that has im-
portant clinical relevance. As a follow-up to our targeted
Figure 1. Graphical view of the term ‘sequence-specific DNA binding transcription factor activity’ (GO:0003700). The grey arrows represent has_part
relationships. The blue arrows represent is_a relationships. The purple arrow represents a regulates relationship. The gold arrows represent part_of
relationships.
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work on heart development (7), we have also met with
community experts to vastly improve the representation
of kidney development in GO. The meeting and subse-
quent work resulted in the addition of over 450 terms to
improve the ontology. Renal system development now
covers the renal systems of flies and vertebrates down to
a cellular level. The structure of the graph represents
similarities and differences that are reflected in major
model organisms used to study renal development.
Improved ontology structure
The GO contains complex terms, particularly in the bio-
logical process ontology. In some cases the terms are
internally referential, such as ‘regulation of cell growth’
(GO:0001558), which refers to both the process of ‘bio-
logical regulation’ (GO:0065007) as well as the process of
‘growth’ (GO:0040007). We have introduced formal
descriptions of these properties into the OBO stanzas of
compound terms (http://wiki.geneontology.org/index.
php/Category:Cross_Products). ‘Regulation of cell
growth’ is formally defined as a ‘biological regulation’
that regulates ‘growth’ (8). The formal descriptions are
used to computationally analyze the placement of a term
in the ontology. In this example, computational reasoning
can be used to infer that ‘regulation of cell growth’ is_a
‘regulation of growth’ (GO:0040008) because ‘cell growth’
(GO:0016049) is_a ‘growth’ (GO:0040007). Compound
logical definitions for terms that express regulates,
occurs_in and part_of relationships now reside in the live
version of the full ontology.
Complex terms in GO can reference both other terms
within GO and terms from other biomedical ontologies
that are outside the scope of GO. In particular, many
biological process terms reference anatomical structures,
cell types and chemicals. For example, the term ‘epithelial
cell differentiation’ refers to the term ‘epithelial cell’
(CL:0000066) from the cell type ontology (4). Formally
cross-referencing terms from external ontologies is a
powerful way to integrate expertise from different special-
ist communities into an existing ontology (8,9). To begin
the formal representation of an external ontology within
GO, we have been deconstructing GO terms that refer to
chemicals and cross-referencing those term to the
Chemicals of Biological Interest (ChEBI) ontology (10).
GO developers have worked closely with ChEBI develop-
ers to assign ChEBI IDs to GO terms that refer to chem-
icals. The chemical references are arranged into a structure
representing the intrinsic chemical hierarchy within GO
(GOChe). Ontology developers use the GOChe to check
alignment of the representation of chemicals in GO with
the representation of chemicals in ChEBI (Figure 2).
When misalignments of the two ontologies are found,
GO curators work with ChEBI curators to resolve the
discrepancy.
Addition of logical definitions into the GO permits the
use of automated reasoning tools to check the logical con-
sistency of the ontology. Reports resulting from these rea-
soning tools are used periodically by ontology developers
to add missing relationships to the ontology and to
identify incorrect relationships that should be modified
or removed.
With formal, computable definitions of GO terms now
represented in the ontology we can add new terms that fit
standard term formats to the ontology without adding
relationships manually. For example many terms such as
‘X involved in Y’ fit into the ontology in a consistent way
where ‘X’ is part_of ‘Y’. Ontology developers use a
web-based tool called TermGenie to add these stereotyp-
ical terms into the ontology. When using TermGenie
ontology editors are prompted to select a template such
as ‘all regulates’, the editor can then choose if they want
all three types of regulation and search for a target
term such as ‘transcription’. Once the term is chosen the
request can be completed and the proper ‘regulation of
transcription’ terms are created with the appropriate rela-
tionships to other terms in the ontology. TermGenie is
currently capable of handling terms in several standard
formats.
IMPROVEMENTS FOR COMMUNITY ACCESS
AmiGO is the GOC’s primary web application that
provides access to annotations and the ontology (http://
amigo.geneontology.org) using the GO database. AmiGO
allows users to browse the ontology and search the anno-
tation corpus. Over the past year, several improvements
were made to the AmiGO resource (Table 3). Term views
are now more informative; displaying the term name, ID,
Figure 2. Graphical view showing the inherent GO-chemical (GOChe)
ontology and ChEBI. Black arrows represent CHEBI is_a relationships.
Blue arrows represent GOChe is_a relationships. Note that the term
‘homopolysaccharide’ only exists in ChEBI.
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definition and subsets of GO in which the term is included.
The term view also has a link to the GONUTS wiki for
users to contribute to information about the usage of
the term (http://gowiki.tamu.edu/wiki/index.php/Main_
Page). At the bottom of the term-view page, there are
several tabbed options for viewing the term in the
context of the rest of the ontology. In particular, there is
an inferred tree view of the term that gives a compact view
of the term in the context of its parents and children, a
view that lists the parents and children of a given term,
and a graphical view of the term using the QuickGO
graphical utility. Additionally, an on-going rewrite of
the software that underlies ‘GOOSE’, the GO online
SQL environment (http://berkeleybop.org/goose) has
been undertaken. Users can also access new software
tools that are under development by the GOC through a
link to AmigoLabs (http://wiki.geneontology.org/index
.php/AmiGO_Labs).
We have also been improving our community outreach
by continuously modifying and enhancing documentation
available through the main web site and the GO wiki. To
keep users and members of the GOC up to date with
respect to changes that are made to the ontologies, we
now provide a weekly report of changes and modifications
to terms and/or their definitions (http://www
.geneontology.org/internal-reports/ontology/).
GO keeps its community informed through two email
lists (go-consortium@lists.stanford.edu and go-friends@
lists.stanford.edu), RSS feeds and social media like
LinkedIn, Facebook and Twitter. We continue to support
our users by responding to queries and data requests
sent to: go-helpdesk@lists.stanford.edu or http://www
.geneontology.org/GO.contacts.shtml.
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J.A. Blake, M. Dolan, H. Drabkin, D.P. Hill, L. Ni, D.
Sitnikov (MGI, The Jackson Laboratory, Bar Harbor,
ME, USA); S. Burgess, T. Buza, C. Gresham, F.
McCarthy, L. Pillai, H. Wang (AgBase, Mississippi State
University; MS, USA); S. Carbon, S.E. Lewis, C.J.
Mungall, (BBOP, LBNL, Berkeley, CA, USA); P.
Gaudet (CALIPHO group, SIB, Geneva, Switzerland);
R.L. Chisholm, P. Fey, W.A. Kibbe, S. Basu (dictyBase,
Northwestern University, Chicago, IL, USA); D.A.
Siegele, B.K. McIntosh, D.P. Renfro, A.E. Zweifel and
J.C. Hu (EcoliWiki, Departments of Biology and
Biochemistry and Biophysics, Texas A&M Univ.,
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Table 3. Enhancements made to the AmiGO tool
GOOSE GO Online SQL Environment http://berkeleybop.org/goose
Visualization Create custom graphical representations of the
ontology
http://amigo.geneontology.org/cgi-bin/amigo/amigo?mode=visualize
Live Search Search annotations or terms and obtain results
automatically in an embedded frame
http://amigo.geneontology.org/cgi-bin/amigo/amigo?mode=live_
search
Homology Set
Summary
Browse gene product annotation summaries from
homology sets coordinately curated by the GOC
http://amigo.geneontology.org/cgi-bin/amigo/amigo?mode=
homolset_summary
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